ARTICLE | Clinical News
Trajenta linagliptin regulatory update
June 27, 2011 7:00 AM UTC
EMA's CHMP issued a positive opinion recommending approval of an MAA for Trajenta linagliptin from Boehringer as monotherapy to treat Type II diabetes in patients inadequately controlled by diet and e...